Special Issue on Different Hemoglobinopathies-Genetic Disorders That are Totally Preventable

Submission Deadline: Nov. 30, 2016

Please click the link to know more about Manuscript Preparation: http://www.ajlabmed.org/submission

  • Lead Guest Editor
    • Rittu Chandel
      Department of Biochemistry, Maharashtra University of Health Sciences, Nashik, Mumbai, Maharashtra, India
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
  • Introduction

    Hemoglobinopathy is defined as a blood disorder caused by a genetically determined change in the molecular structure of hemoglobin. Abnormalities of hemoglobin (Hb) synthesis are among the most common inherited disorders of man and can be quantitative (thalassemia syndrome) or qualitative (variant Hbs). Screening is a process used to identify individuals who are at high risk of having or of developing, a specific disease when compared with the general population. From the obstetrician’s point of view, prevention and control in pregnant women is one of the best ways to reduce the birth of severe thalassemia major infants. Three major aspects of prevention and control are carrier detection, genetic counseling and prenatal diagnosis. In India, beta thalassemia is the most common monogenic disorder. Unlike many other genetic disorders where couple at risk cannot be easily diagnosed, thalassemia and abnormal hemoglobin give a tremendous opportunity for effective control of birth. Screening in antenatal clinics is the best way to identify couples at immediate risk of having an affected child. This emphasizes the need for generating awareness in the population for early registration in antenatal clinics as well as among obstetricians to ask for a screening for β-thalassemia and other hemoglobinopathies along with other investigations which are done routinely.

    Aims and Scope:

    1.Screening of different populations for existing hemoglobinopathies
    2.Reporting different kinds of Hemoglobinopathies
    3.Clinical Biochemistry behind the genetic disorder
    4.Simple laboratotry tests that detect these genetic disorders
    5.Prenatal diagnostic methods for the detection of hemoglobinopathies in the fetus
    6.educating the masses and spreading awareness regarding these totally preventable genetic disease
    7.Lack of detection causes financial, psychological and mental trauma on the patient and their family
    8.Complications due to blood transfusion
    9.Complicatioms due to excessive Iron therapy
    10.Hormonal disorders in patients of hemoglobinopathies

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ajlabmed.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.